Feng Yu Kuo

METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS

R. Clark Lantz, Todd A. Gillespie, T. J. Rash et al. · Drug Metabolism and Disposition · 2003 · 207 citations

Medicine, Pharmacokinetics, Pharmacology +17

2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome

Yi‐Heng Li, Yu-Chen Wang, Yi‐Chih Wang et al. · Journal of the Formosan Medical Association · 2018 · 56 citations · Full text

Medicine, Cardiology, Internal Medicine +17

TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells

Kai‐Chun Cheng, Wei‐Ting Chang, Feng Yu Kuo et al. · Scientific Reports · 2019 · 52 citations · Full text

Life Sciences, Biochemistry, Pharmacology +12

The effect of failure mode and effect analysis on reducing percutaneous coronary intervention hospital door-to-balloon time and mortality in ST segment elevation myocardial infarction

Feng Yu Kuo, Wei-Chun Huang, Kuan-Rau Chiou et al. · BMJ Quality & Safety · 2013 · 20 citations

Medicine, Cardiology, Cardiothoracic Surgery +16

Five-Year Outcomes after Acute Myocardial Infarction in Patients with and without Diabetes Mellitus in Taiwan, 1996-2005.

Cheng Hung Chiang, Wei Huang, Jin Yang et al. · PubMed · 2013 · 17 citations

Medicine, Cardiology, Internal Medicine +16